Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2024-04-24 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2023年度独立董事述职报告（王秀萍）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2023, detailing the director's duties, attendance, opinions on board matters, committee participation, and governance activities. It includes references to the review and approval of the 2022 annual report and 2023 quarterly report but does not itself contain financial statements or detailed financial data. The document focuses on governance and management oversight rather than presenting financial results or audit findings. It is a detailed management/board-related report about the director's role and activities, fitting best under Board/Management Information (MANG).
2024-04-24 Chinese
会计师事务所选聘制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '会计师事务所选聘制度' (Accounting Firm Selection System) for a company, outlining procedures, requirements, and governance related to the selection and appointment of accounting firms for audit purposes. It references regulatory bodies such as the China Securities Regulatory Commission and legal frameworks but does not contain any financial statements, audit opinions, or actual audit reports. It is a governance and procedural document related to audit firm selection rather than an audit report or annual report itself. Therefore, it fits best under Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2024-04-24 Chinese
2023年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2023 年年度报告摘要" which translates to "2023 Annual Report Summary". It contains detailed financial data including main business descriptions, accounting policies, financial indicators over multiple years, quarterly financial data, shareholder information, and other comprehensive company information typical of an annual report. The document length is over 13,000 characters, indicating it is a substantive report rather than a brief announcement. There is no indication that this is merely a notice of report publication or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-04-24 Chinese
会计差错更正后财务报表及相关附注
Annual Report Classification · 95% confidence The document is titled as "成都市贝瑞和康基因技术股份有限公司 会计差错更正后财务报表及相关附注" which translates to "Chengdu Berry Genomics Co., Ltd. Financial Statements and Related Notes After Correction of Accounting Errors." It contains detailed financial statements including balance sheets, profit and loss statements, cash flow statements, and changes in equity for the years 2021 and 2022. The content includes comprehensive financial data and notes, indicating it is a full financial report rather than a brief announcement or certification. The presence of corrected financial statements suggests it is a formal financial report, likely an annual report or a restated annual report. Given the detailed financial data and the nature of the document, it fits best under the category of Annual Report (10-K). FY 2021
2024-04-01 Chinese
第十届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the company's 10th Board of Directors 7th meeting, including approval of accounting error corrections and extension of an employee stock ownership plan. It is a formal disclosure of board decisions and meeting outcomes, not a full financial report or audit report. The document length is short (1343 characters) and it primarily reports board meeting resolutions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management.
2024-03-29 Chinese
前期会计差错更正专项说明审核报告
Audit Report / Information Classification · 95% confidence The document is an audit report specifically focused on the correction of prior period accounting errors by the company 成都市贝瑞和康基因技术股份有限公司. It includes the auditor's responsibility, management's responsibility, audit procedures, and the audit opinion on the special explanation of prior accounting error corrections. It references relevant accounting standards and regulatory disclosure rules. The document contains detailed financial adjustments and audit conclusions but is not a full annual or interim report. It is a standalone audit report related to accounting policy changes and error corrections, which fits the definition of an Audit Report / Information (AR). The document length is over 5,000 characters and contains substantive financial data and audit opinion, so it is not a mere announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2023
2024-03-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.